Literature DB >> 16785750

Experimental model for proliferative vitreoretinopathy by intravitreal dispase: limited by zonulolysis and cataract.

Martina T Kralinger1, Gerhard F Kieselbach, Monika Voigt, Brandy Hayden, Eleut Hernandez, Viviana Fernandez, Jean-Marie Parel.   

Abstract

BACKGROUND: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method.
METHODS: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units.
RESULTS: Proliferative vitreoretinopathy occurred in 81% of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes.
CONCLUSION: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785750     DOI: 10.1159/000093073

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

1.  The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.

Authors:  Qianying Gao; Wencong Wang; Yuqing Lan; Xiaoqing Chen; Wei Yang; Yongguang Yuan; Juan Tan; Yao Zong; Zhaoxin Jiang
Journal:  Int J Nanomedicine       Date:  2013-04-19

2.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

3.  Pharmacologic vitreolysis.

Authors:  Hossein Nazari; Mehdi Modarres-Zadeh; Arash Maleki
Journal:  J Ophthalmic Vis Res       Date:  2010-01

4.  Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice.

Authors:  Juan Tan; Yaqin Liu; Wei Li; Qianying Gao
Journal:  Mol Vis       Date:  2012-04-07       Impact factor: 2.367

5.  Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy.

Authors:  W Zhang; J Tan; Y Liu; W Li; Q Gao; P V Lehmann
Journal:  Eye (Lond)       Date:  2012-03-30       Impact factor: 3.775

6.  Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy.

Authors:  Yali Lyu; Wei Xu; Jieping Zhang; Mengwen Li; Qingyi Xiang; Yao Li; Tianhao Tan; Qingjian Ou; Jingfa Zhang; Haibin Tian; Jing-Ying Xu; Caixia Jin; Furong Gao; Juan Wang; Weiye Li; Ao Rong; Lixia Lu; Guo-Tong Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

7.  Endogenous or Exogenous Retinal Pigment Epithelial Cells: A Comparison of Two Experimental Animal Models of Proliferative Vitreoretinopathy.

Authors:  Chee Wai Wong; Joanna Marie Fianza Busoy; Ning Cheung; Veluchamy Amutha Barathi; Gert Storm; Tina T Wong
Journal:  Transl Vis Sci Technol       Date:  2020-08-31       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.